Literature DB >> 29186716

Müller Cell-Derived PEDF Mediates Neuroprotection via STAT3 Activation.

Wolfram Eichler1, Helena Savković-Cvijić1, Susanne Bürger1, Mike Beck1, Manuela Schmidt1, Peter Wiedemann1, Andreas Reichenbach2, Jan Darius Unterlauft1.   

Abstract

Background/ Aims: This study was performed to reveal signaling pathways exploited by pigment epithelium-derived factor (PEDF) derived from retinal (glial) Müller cells to protect retinal ganglion cells (RGCs) from cell death.
METHODS: The survival of RGCs was determined in the presence of conditioned culture media (MCM) from or in co-cultures with Müller cells. The significance of PEDF-induced STAT3 activation was evaluated in viability assays and using Western blotting analyses and siRNA-transfected cells.
RESULTS: Secreted mediators of Müller cells increased survival of RGCs under normoxia or hypoxia to a similar degree as of PEDF- or IL-6-exposed cells. PEDF and MCM induced an increased STAT3 activation in RGCs and R28 cells, and neutralization of PEDF in MCM attenuated STAT3 activation. Inhibition of STAT3 reduced PEDF-promoted survival of RGCs. Similar to IL-6, PEDF induced STAT3 activation, acting in a dose-dependent manner via the PEDF receptor (PEDF-R) encoded by the PNPLA2 gene. Ablation of PEDF-R attenuated MCM-induced STAT3 activation and compromised the viability of PEDF-exposed R28 cells.
CONCLUSIONS: Müller cells are an important source of PEDF, which promotes RGC survival through STAT3 activation and, at least in part, via PEDF-R. Enhancing the secretory function of Müller cells may be useful to promote RGC survival in retinal neurodegenerative diseases.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Müller cells; Neuroprotection; PEDF; Retinal ganglion cells

Mesh:

Substances:

Year:  2017        PMID: 29186716     DOI: 10.1159/000485537

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  8 in total

Review 1.  Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology.

Authors:  Olvera-Montaño Cecilia; Castellanos-González José Alberto; Navarro-Partida José; Cardona-Muñoz Ernesto Germán; López-Contreras Ana Karen; Roman-Pintos Luis Miguel; Robles-Rivera Ricardo Raúl; Rodríguez-Carrizalez Adolfo Daniel
Journal:  J Diabetes Res       Date:  2019-08-14       Impact factor: 4.011

2.  JIP1 Deficiency Protects Retinal Ganglion Cells From Apoptosis in a Rotenone-Induced Injury Model.

Authors:  Wenyi Liu; Xue Li; Xi Chen; Jieqiong Zhang; Linlin Luo; Qiumei Hu; Jiaxing Zhou; Jun Yan; Sen Lin; Jian Ye
Journal:  Front Cell Dev Biol       Date:  2019-10-15

3.  TNFα-Mediated Priming of Mesenchymal Stem Cells Enhances Their Neuroprotective Effect on Retinal Ganglion Cells.

Authors:  Ben Mead; Xitiz Chamling; Donald J Zack; Zubair Ahmed; Stanislav Tomarev
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

Review 4.  Immunological Insights in Equine Recurrent Uveitis.

Authors:  Roxane L Degroote; Cornelia A Deeg
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

Review 5.  Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets.

Authors:  Shen Nian; Amy C Y Lo; Yajing Mi; Kai Ren; Di Yang
Journal:  Eye Vis (Lond)       Date:  2021-05-01

6.  Pigment Epithelium-Derived Factor (PEDF) Receptors Are Involved in Survival of Retinal Neurons.

Authors:  Susanne Bürger; Jie Meng; Annette Zwanzig; Mike Beck; Maik Pankonin; Peter Wiedemann; Wolfram Eichler; Jan Darius Unterlauft
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

7.  IL-17A injury to retinal ganglion cells is mediated by retinal Müller cells in diabetic retinopathy.

Authors:  Ao-Wang Qiu; Da-Rui Huang; Bin Li; Yuan Fang; Wei-Wei Zhang; Qing-Huai Liu
Journal:  Cell Death Dis       Date:  2021-11-08       Impact factor: 8.469

Review 8.  Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead.

Authors:  Raquel Boia; Noelia Ruzafa; Inês Dinis Aires; Xandra Pereiro; António Francisco Ambrósio; Elena Vecino; Ana Raquel Santiago
Journal:  Int J Mol Sci       Date:  2020-03-25       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.